Jitesh Pratap to Bone Neoplasms
This is a "connection" page, showing publications Jitesh Pratap has written about Bone Neoplasms.
Connection Strength
3.095
-
Bone metastatic breast cancer cells display downregulation of PKC-? with enhanced glutamine metabolism. Gene. 2021 Apr 05; 775:145419.
Score: 0.721
-
The role of Runx2 in facilitating autophagy in metastatic breast cancer cells. J Cell Physiol. 2018 Jan; 233(1):559-571.
Score: 0.560
-
Role of Runx2 in IGF-1R?/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis. Oncogene. 2016 09 08; 35(36):4730-40.
Score: 0.511
-
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Mol Cancer Ther. 2010 Dec; 9(12):3210-20.
Score: 0.358
-
Metastatic bone disease: role of transcription factors and future targets. Bone. 2011 Jan; 48(1):30-6.
Score: 0.345
-
Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008 Oct 01; 68(19):7795-802.
Score: 0.308
-
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol. 2005 Oct; 25(19):8581-91.
Score: 0.250
-
Integrin av?6 promotes an osteolytic program in cancer cells by upregulating MMP2. Cancer Res. 2014 Mar 01; 74(5):1598-608.
Score: 0.028
-
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1454-9.
Score: 0.015